People

Peter Greaney is venture partner at Eckuity Capital. Physician and WorkCare founder contributing occupational-health services experience. WorkCare’s own current directory calls him founder and chief medical officer; outside executive-chair claims are historical or unconfirmed.

Daniel Glasser is Neurala’s senior vice president of operations. His technology-delivery experience spans large companies, government agencies and startups. His current responsibilities cover operating plans, team development, revenue operations and commercial partnerships. He earned an MBA at Boston University’s Questrom School of Management.

Dan Curtis leads Neurala’s finance function. His published career spans public companies, venture-backed businesses and Big Four accounting, with experience in corporate transactions and operational finance. He previously served as CFO at Vitrue, Kova Solutions and SiteAdvisor, companies subsequently acquired by Oracle, Berkshire Hathaway and McAfee respectively. He earned an honors bachelor’s degree from Boston College. Fundraising totals in his career biography are not attributed as capital raised by Neurala.

Peter Cicala is venture partner at Eckuity Capital. Pharmaceutical intellectual-property strategist and former Celgene patent executive; contributes legal and commercialization expertise.

Elaine Pang is head of portfolio operations at Eckuity Capital. Coordinates portfolio operations, operational support and collaboration among Eckuity’s healthcare businesses.

Anatoli Gorchet is Neurala’s current co-founder, chief executive officer and chief technology officer. The company identifies him as the computational neuroscience architect of its Lifelong Deep Neural Network. He has over two decades of experience in parallel neural computing, including early application of GPUs to neural modeling. His background includes a PhD in Cognitive and Neural Systems at Boston University and a master’s degree in computer science. His public work includes neural network publications, patents and advising businesses on AI deployment. The company’s original named portrait uses the longer name Anatoly Gorshechnikov in its asset filename; this alias is retained as provenance rather than a second person.

Ken Eagle is cfo at Eckuity Capital. Listed as CFO in Eckuity’s current public directory, responsible for fund finance and reporting. Earlier legal filings separately name Jonny He; they are distinct people.

Paige Leonard’s public self-profile identifies SideBy Care as her current employer in the Denver/Boulder area. Her background includes Virginia Tech business education and communications work. She received a 2024 National Council for Mental Wellbeing advocacy award and Colorado Healthcare Communicators recognition. The specific current SideBy Care title is not visible in the accessible primary profile.

Anna Juarez, LPC, is a Louisiana mental-health counselor whose current self-profile identifies SideBy Care. She studied at the University of Louisiana at Lafayette Graduate School and previously worked as a journalist. Her self-submitted practitioner profile describes virtual counseling, anxiety, depression, trauma and EMDR. A dated practitioner directory’s provisional-license wording is not treated as a current regulator verification.

Heather Ames is a cognitive scientist and Neurala co-founder whose work helped translate neuroscience research into a commercial AI business. The company credits her with shaping its organizational and commercial foundations. Its present leadership directory lists her in the co-founder section and does not assign her a current executive operating title.

Ryan Green is coo & head of investor relations at Eckuity Capital. Oversees Eckuity’s operations and investor relationships, including fund administration and investor communications.

Angel Lewis, MA, LPC, is a licensed professional counselor whose current public self-profile identifies SideBy Care. Her own recent posts discuss the company’s gut–brain care programme and Unio Specialty Care partnership. Her accessible professional profile describes more than eight years of mental-health experience; the specific employer title and appointment date are not published.

Jason Criscione is operating partner at Eckuity Capital. Biomedical engineer and healthcare entrepreneur supporting portfolio development; founded Enquyst Technologies and earned a Yale biomedical-engineering PhD.

Sarah Volling, MS, RD, LDN, CDCES, is a registered dietitian whose current self-profile identifies SideBy Care. She also owns Eat Practical in Edwardsville, Illinois. Her own practitioner biography describes gastrointestinal nutrition and diabetes-care qualifications, with undergraduate training at Kansas State University and graduate training at Fontbonne University. Her employer-specific SideBy Care title is not visible in the accessible primary profile.

Max Versace, also known as Massimiliano Versace, is a neuroscientist and entrepreneur who co-founded Neurala and led its research commercialization and growth as CEO. His training includes doctoral study in cognitive and neural systems at Boston University and experimental psychology at the University of Trieste. His current own biography identifies subsequent leadership of Emergent AI at Analog Devices. Neurala now lists him among its co-founders, while its current CEO is Anatoli Gorchet. His earlier CEO title is retained as historical rather than current.

Jessica Person Eckert, MPH, RDN, LDN, is a registered dietitian based in Lafayette, Louisiana. Her public self-profile identifies SideBy Care as her current employer and her own posts describe working with its virtual care team. She studied at Tulane University. The employer-specific title is not visible in the accessible primary profile.

Ambre Millon is investment analyst at Eckuity Capital. Works on financial analysis, market research and transaction diligence; studied business management at Bayes Business School.

Waez Umer is investment analyst at Eckuity Capital. Combines medical training and investment analysis to evaluate healthcare businesses and monitor the portfolio.

Michael Salako is principal at Eckuity Capital. Evaluates and executes healthcare investments, drawing on biomedical engineering and venture-investment experience. Michael Salako was Start Codon senior investment associate in the Cambridge2020 report and investment director in2021–2024 primary partner/event publications. His Bristol speaker biography describes previous Cancer Research UK commercialisation, a biochemistry degree, molecular virology/toxicology PhD, MBA and immuno-oncology postdoctoral research. These historical Start Codon roles do not replace his preserved Eckuity affiliation; the same own-linked professional LinkedIn identity corroborates the match.

Karim Maasarani is general partner at Eckuity Capital. Leads portfolio operations and commercial development across Eckuity’s healthcare investments.

Victoria Manax Rutson is general partner at Eckuity Capital. Physician and life-sciences investor contributing oncology, clinical-development and healthcare commercialization experience.

Youssef Sebban is managing partner at Eckuity Capital. Founded Eckuity’s healthcare investment platform and leads its investment strategy and portfolio development.

Matthew K. Stepan is identified as a director and vice president of Omidyar Technology Ventures, LLC in Akili’s2022 SEC beneficial-ownership disclosure. Current OTV tenure and a verified public portrait were not established. No identity association with similarly named real-estate professionals is assumed.

Robinson C. Jacobs is identified as a director and vice president of Omidyar Technology Ventures, LLC in Akili’s2022 SEC beneficial-ownership disclosure. Current OTV tenure and a verified public portrait were not established; this statutory affiliation is source-qualified as historical.

Jeffrey R. Alvord is identified as a director and president of Omidyar Technology Ventures, LLC in Akili’s2022 SEC beneficial-ownership disclosure, which spells his given name Jeffery. Other official Omidyar-affiliated filings identify Jeffrey R./Jeffrey Robert Alvord. Current OTV tenure and a verified public portrait were not established.

Pierre Omidyar founded eBay and created and solely funded Omidyar Technology Ventures, according to its official archived website. The distinct Omidyar Network also identifies him as its co-founder. The OTV affiliation does not imply personal attribution of every portfolio check or a pooled investment fund close.

Pearl Chan, also publicly known as Pearl Chan Schopmeyer, joined the founding Omidyar Technology Ventures team in2015 and was its Principal in the2017 official directory. She previously worked at Omidyar Network, Goldman Sachs and Tinicum. Her own2019 account states she left the Omidyar group to build Snowball Wealth; the OTV role is historical.

Chris Bishko was a Partner at Omidyar Technology Ventures in its2017 official directory, following investment roles at Omidyar Network and JPMorgan. He studied biomedical engineering and English at Duke University. This is a historical OTV affiliation, not a claim of current employment.

Todor Tashev was Managing Partner of Omidyar Technology Ventures on its official archived public directory, including the January2021 homepage. He previously led global technology investments at Omidyar Network, worked on Tellme Networks mobile applications and made venture/private-equity investments at JPMorgan. His education includes Harvard Business School and Carleton University. Current OTV tenure is unconfirmed.

Norah (Cliff) Candito, MS, RDN, LDN, CLC, is a registered dietitian and Director of Clinical Operations at SideBy Care, as confirmed by her own Nutrition with Norah practitioner biography. She founded that practice, took it full-time in January2022 and focuses on gastrointestinal and hormonal health. She is based in Rhode Island and appeared with Sahil Patel in a primary SideBy Care clinical interview.

Dan Judkins is a toy-design executive and co-founder of The AI Toy Company, formerly Magical Toys. The company names him Chief Product Officer in its Bondu launch press release and direct email interview.

Fateen Anam Rafid co-founded The AI Toy Company, formerly Magical Toys, which makes Bondu. He is named founder and CEO in its October 2025 issuer press release; the company’s April 2026 educational articles identify him as Fateen Anam, CEO at Bondu.

Igor Jablokov founded Pryon and is listed as its Chairman, CEO, and a director in its current leadership directory. He previously founded cloud speech-recognition company Yap, which Amazon acquired, and led multimodal and speech technology work at IBM.

Sahil R. Patel, MD, is co-founder and Chief Medical Officer of SideBy Care. The March2026 Unio Specialty Care partnership announcement identifies him as CMO; SideBy’s own 2026 presentation identifies the co-founder title. He is a gastroenterologist whose self-submitted Keystone GI Consultants clinical profile describes SideBy Care and lists board certification in gastroenterology and internal medicine. His medical education and residency are listed at St. George’s University and Drexel University.

Patrick Leonard is CEO and co-founder of SideBy Care, an AI-assisted virtual care company for disorders of gut–brain interaction. He previously led CVS Health Virtual Care products, served as CTO of iTriage and built Aetna Digital, and co-founded AI medical-documentation company Sopris Health. His direct December2025 founder interview confirms these roles.

Nina Kandilian is a director in First Citizens Innovation Banking’s investor-coverage team, focused on healthcare and life-science venture relationships. Her prior experience includes MassChallenge HealthTech, healthtech product marketing and strategy, and digital transformation at Mass General Brigham. She studied at Suffolk University and Babson College.

Alex Lennox-Miller is a lead research analyst in First Citizens Innovation Banking’s Market Insights group, covering life sciences and healthcare. His earlier roles include healthcare analysis at CB Insights, Chilmark Research and Beth Israel Lahey Health. He studied anthropology at UMass Boston and earned an MBA at Northeastern University. The current published title is used despite older senior-analytics wording in his page biography.

Andrew Pardo is a principal researcher in First Citizens Innovation Banking’s Market Insights group in San Francisco. He covers capital markets, fundraising and exits across innovation economies. His earlier work was in buy-side financial-sector equity research, and he studied accounting at Loyola Marymount University.

Jake Ledbetter is a senior researcher at First Citizens Innovation Banking working on private-equity and venture-capital research. Before joining SVB in 2022, he worked at Bella Research Group. He holds economics degrees from Duke University and the University of Alabama at Birmingham and is a CFA charterholder.

Josh Pherigo is a principal researcher in the Market Insights group at First Citizens Innovation Banking. He produces research and data analysis covering the innovation economy and venture-capital ecosystem. The bank publishes him as an author of its current State of the Markets and healthcare reports.

Eli Oftedal is a principal researcher in First Citizens Innovation Banking’s Market Insights group. He analyzes venture investment, fundraising and exits, with a particular interest in climate technology. His earlier experience includes clean-energy venture investing, and he studied ecosystem science, economics and liberal arts at Colorado State University.

Adam Tweedy leads life-science and healthcare investor coverage at First Citizens Innovation Banking. He previously led corporate-liquidity and fund-banking teams and works with sector investors on banking services and strategic relationships. His education includes graduate business study at Babson College.

Andy Tsao leads Global Gateway at First Citizens Innovation Banking, supporting emerging-market innovation businesses and their US expansion. His banking career includes international venture relationships, technology lending and establishing SVB’s UK office. He studied at Colgate University and Boston University.

Nigel Topping is a fund adviser and investment committee member in All Aboard’s published strategy presentation, which separately identifies his climate leadership affiliations.

John Arnold is a fund adviser and investment committee member in All Aboard’s published strategy presentation. His philanthropic Arnold Ventures affiliation is separate from the venture fund manager.

Jay Dessy is CIO of All Aboard Fund, named in co-founder True North Institute’s current report and the manager’s own public appointment announcement. He previously worked at Graphyte, Breakthrough Energy Catalyst and Gates Ventures, scaling novel climate technology and first-of-a-kind infrastructure.

Camille Zivré is included in All Aboard Investment Management Company’s published internal team. The presentation identifies her separate Exa Ventures principal role and earlier byFounders, Inventure and Korelya experience. The outside principal title is not assigned to All Aboard.

Tove Lilliestierna is included in All Aboard Investment Management Company’s published internal team. The presentation identifies her separate Exa Ventures partner role and earlier Norrsken, Bain and Citi experience. The outside partner title is not assigned to All Aboard.

Tristan Varakuta is included in All Aboard Investment Management Company’s published internal team. The presentation identifies his separate role as Investment Associate at True North Institute and previous L.E.K. consulting experience. That outside title is not assigned to All Aboard.

Jack Haynes is included in All Aboard Investment Management Company’s published internal team. The presentation identifies his separate role as Head of Investments at True North Institute and earlier experience at Marwyn and PwC. That outside title is not assigned to All Aboard.

Megan Wenrich is COO of All Aboard Fund, as named in co-founder True North Institute’s current year-in-review report. The manager’s November 2025 strategy presentation previously listed her as Head of Capital Formation.

Staffan Qvist is a General Partner of All Aboard Fund and investment committee member. The manager’s presentation identifies him as CEO of QuantifiedCarbon, founder of Deepsense and Managing Partner of Exa Ventures.

Chris Anderson is Co-founder and General Partner of All Aboard Fund and serves on its investment committee. The manager’s presentation identifies his TED, Exascale/Exa Ventures and Thorcon affiliations. This is the TED curator, not an inferred match to other people named Chris Anderson.

Stan Miranda is Co-founder and General Partner of All Aboard Fund. The manager’s investment presentation identifies him as lead manager and investment committee member. He founded True North Institute and Partners Capital.

Adeline Boatin is named in CBIV’s current advisory directory. Her precise strategic-versus-scientific board assignment is not resolved by the accessible directory text; the generic advisory title preserves the disclosed affiliation without inferring employment.

Guilherme Sant’Anna is named in CBIV’s current advisory directory. His precise strategic-versus-scientific board assignment is not resolved by the accessible directory text; the generic advisory title preserves the disclosed affiliation without inferring employment.

Alyson J. McGregor is named in CBIV’s current advisory directory. The issuer’s original launch identifies her as a scientific adviser specializing in sex and gender differences in disease.

Marjorie Jenkins is named in CBIV’s current advisory directory; the issuer’s original launch identifies her as a scientific adviser with expertise in women’s health and sex and gender differences.

Dana Deardorff is named in CBIV’s current advisory directory. Her precise strategic-versus-scientific board assignment is not resolved by the accessible directory text; the generic advisory title preserves the disclosed affiliation without inferring employment.

Published in CBIV’s current advisory directory. The issuer’s original launch identifies her as a strategic adviser and Grand Challenges Canada leader.

Published in CBIV’s current advisory directory. The issuer’s original launch identifies her as a strategic adviser with global health and Becton Dickinson experience.

Published in CBIV’s current advisory directory. The issuer’s original launch identifies her as a strategic adviser with BabyCenter and Johnson & Johnson operating experience.

Published in CBIV’s current advisory directory. The issuer’s original launch identifies him as a strategic adviser with healthcare technology, strategy and commercialization experience.

Tasha Noronha manages partnerships and operations at CBIV. She previously supported operations and key funder relationships at Grand Challenges Canada Foundation and worked with the Every Woman Every Child Innovation Marketplace. She holds an international development studies degree from the University of Toronto.

Megan Dover is Partner and Co-founder of CBIV. Her experience spans impact investing, venture advisory, M&A, corporate strategy, finance and biomedical research. Before the firm’s launch she advised health technology companies and helped mobilize equity and non-dilutive funding. She holds an MBA from Rotman and an engineering degree from Queen’s specializing in biomedical research within chemical engineering.

Juanita Cortés is CFO at CBIV and a public accountant and auditor qualified in Mexico with more than 25 years of Canadian experience. Her work spans financial planning, audits, IPOs and M&A across private equity, nonprofits, SaaS, manufacturing and other sectors, with GAAP, US GAAP, IFRS and ASPE experience.

Issy Gordon leads investments at CBIV. She spent five years at Salica Investments, formerly Hambro Perks, where she developed its healthcare strategy and worked with Daye, Peppy, Lindus Health, Suri and Theremia. Her earlier work includes Deloitte M&A and product and growth roles at Percent and Asset Vault. She holds a London Business School management master’s degree.

Hannah Sharpe works at the intersection of environment and health at CBIV. She previously advised the Municipality of Caledon on sustainability and climate resilience and led life science and strategy work at Heal Mary Technologies, an AI platform matching oncology patients to clinical trials. She holds a master’s in environment and sustainability and a biology degree from Western University.

Femke Smeets leads emerging-market work at CBIV, drawing on close to 20 years in healthcare financing, business development, capacity building and impact management across Africa, Latin America, the US and Europe. Her experience includes health SME fund technical assistance, digital health and health insurance platforms, and healthcare project finance.

Donna Parr is Managing Partner at CBIV, with more than 30 years of experience managing venture capital, growth equity and private debt portfolios. She previously managed the GrowthWorks Canadian Fund and Canadian Medical Discoveries Fund and worked at OMERS and CPP. CBIV identifies her as a director of Constellation Software and Topicus.com.

Annie Thériault is Managing Partner at Cross-Border Impact Ventures and an investor in inclusive health technology. She previously served as Chief Investment Officer at Grand Challenges Canada and has worked in venture capital, impact investing, royalty financing and capital markets strategies. She holds a management PhD from the Rotman School, is a CFA charterholder and holds the ICD.D designation.

Mark Gallagher leads investor coverage and business development at First Citizens Innovation Banking. His career includes technology and life-science banking, corporate venture relationships and regional business development at SVB. He works with investors and venture firms on banking services and strategic connections.

Mike Tramack leads loan administration at First Citizens Innovation Banking and is a member of its commercial-bank leadership team. His team oversees underwriting, credit decisions and portfolio governance. His SVB career began in 1998; he holds degrees from Stonehill College and Boston College.

Megan Scheffel leads First Citizens Innovation Banking’s life-science and healthcare business and its nationwide sector team. Her innovation-finance career at SVB began in 1997 and includes international credit leadership and technology-banking roles. She studied business administration and finance at the University of Colorado Boulder.

Marc Cadieux is president of First Citizens Innovation Banking, the current technology and healthcare banking division formerly branded Silicon Valley Bank. He joined SVB in 1992 and held senior credit and sales positions, including chief credit officer from 2013, before becoming commercial-bank president in 2023. He studied economics at Colby College. His current title is confirmed by the bank’s October 2026 launch announcement.

Roy Beveridge is a physician and healthcare executive with former chief medical officer responsibilities at Humana. His authenticated portrait and physician biography are preserved from the Wharton Healthcare Management Alumni Association’s historical publication. Positive Development’s January2025 SEC filing lists him as a director; that filing does not establish his present issuer board status.

Mark Pacala is a healthcare operating and private-equity advisor, published by National Partners in Healthcare as its chairman. His experience includes executive roles at American WholeHealth and the Forum Group, and investment work at Essex Woodlands. He holds degrees from Hamilton College and Harvard Business School. Positive Development’s January2025 SEC filing reports his directorship; current issuer board status is unverified.

Nick Whitehead, also published by B Capital as Nicholas Whitehead, is a Senior Principal focusing on early-stage investments. He previously supported the firm’s platform and capital-formation activities and worked at RBS and Houlihan Lokey. He holds an MBA from Columbia and an economics degree from Wharton. Positive Development’s January2025 SEC disclosure names him as a director; current issuer board status is not separately published. Current primary B Capital biography reviewed October8,2026: Our Team Nick Whitehead Senior Principal Function: Investment Location: Americas - San Francisco Stage: Early Stage, Growth Stage Expertise: Healthcare LinkedIn Nick Whitehead is a Senior Principal at B Capital, where he focuses on early-stage investments. Before transitioning to his current role, Nick worked on B Capital’s Platform team, supporting Capital Formation and follow-on fundraising for the portfolio. Prior to joining B Capital, he worked in investment banking at RBS in Hong Kong and the Financial Institutions Group at Houlihan Lokey in New York. He later founded a healthcare technology company and launched a consulting business advising early-stage startups on finance, fundraising and operations. Nick holds an MBA from Columbia Business School and a B.S. in Economics from the Wharton School at the University of Pennsylvania. He is based in San Francisco. Related Content 1/3 Article | Why We Invested Why We Invested: Flourish Health July 30, 2026 By: Adam Seabrook, Nick Whitehead and Athena Shea   B Capital is thrilled to announce its investment in Flourish Health,… Learn More → 2/3 Article | Why We Invested Why We Invested: Cadence June 25, 2026 By: Robert Mittendorff, MD, Adam Seabrook, Nick Whitehead, Athena Shea, and Keegan McGuire   B Capital is proud to partner… Learn More → 3/3 Article | Why We Invested Why We Invested: Innovaccer December 15, 2021 Author: Nick Whitehead; co-contributor Shwan Kazzaz The US healthcare market represents approximately 18% of GDP, and yet while spend has increased… Learn More →

Adam Seabrook is a B Capital partner investing in healthcare and digital health. His experience includes Hyde Park Angels and healthcare startup Imaging Advantage. He holds an MBA from the University of Chicago and an engineering bachelor’s degree from Cornell. B Capital’s own biography documents his Positive Development board service. Current primary B Capital biography reviewed October8,2026: Adam Seabrook is a Partner at B Capital leading the firm’s investments in Healthcare and Digital Health. Prior to joining B Capital, Adam worked at Hyde Park Angels, one of the largest angel networks in the United States. At B Capital, he has invested in and served on the board of companies such as Positive Development, Synapticure, Atomwise, Evidation, Sift Healthcare and PicnicHealth, among others. Adam was an early employee at Imaging Advantage, a teleradiology startup recently acquired by Envision Healthcare, where he managed implementation at hospitals around the United States, led workflow optimization efforts and helped acquire physician practices as part of a rollup strategy. As a result of a proposal Adam co-wrote to the Centers for Medicare & Medicaid Services, the company was awarded $6 million to develop a decision support tool for physicians. Adam was recently named to GrowthCap’s Top 40 Under 40 Growth Investors . Adam earned an MBA from the University of Chicago and a BS in Mechanical and Biomedical Engineering from Cornell University. He is based in Los Angeles.

Tomer Berkovitz is a Managing Partner at aMoon. He joined in2018 after roles in healthcare finance at J.P.Morgan and as Alcobra’s CFO and COO. He holds a finance PhD from Columbia. Positive Development announced his board appointment with its August2025 SeriesC financing. Tomer Berkovitz is published by aMoon as Managing Partner. Healthcare finance specialist who joined in2018 after J.P.Morgan investment banking and Alcobra executive roles.

Jon Pardew is a healthcare strategic advisor and former President and CEO of CCRM Fertility. Previously he led healthcare investment-banking work at St. Charles Capital. Positive Development appointed him to its board effective May1,2026. Its announcement also identifies Healix and Oula Health board service. An authenticated individual portrait was not retrieved.

Alisa Bahl is a clinical psychologist and President of The Bahl Group. Her career includes behavioral-health operations and payer strategy, formerly as Magellan Health’s chief strategy and innovation officer and Optum Health’s senior vice president of clinical solutions. Positive Development appointed her to its board effective May1,2026.

Previously co-founded ID8 Investments, Facteus and Artisan Council and worked in investment banking at Morgan Stanley.

Founder of TOBO.CREATIVE, with marketing and startup growth experience.

Investor and entrepreneur working across health innovation and mental-health capital.

Medtech commercial strategist and former Visionsense commercial leader.

Behavioral scientist and founding director of the YU Innovation Lab, with U.S. commercialization experience.

Neurotechnology entrepreneur who founded surgical visualization company Visionsense and previously led Joy Ventures.

Josh Feder is Executive Medical Director at Positive Development, according to the company’s current public directory. The company publishes the credentials MD. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Partha Boocha is Chief Technology Officer at Positive Development, according to the company’s current public directory. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Paul Bohlander is Chief Product Officer at Positive Development, according to the company’s current public directory. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Kate Rollins is Chief Clinical Officer at Positive Development, according to the company’s current public directory. The company publishes the credentials MSN, RN. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Greg Fuller is Chief Operating Officer at Positive Development, according to the company’s current public directory. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Chad Pomeroy is President at Positive Development, according to the company’s current public directory. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

John Banta is Co-founder & Executive Chairman at Positive Development, according to the company’s current public directory. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Mike Suiters is Co-founder & Chief Executive Officer at Positive Development, according to the company’s current public directory. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Lauren Svymbersky is Clinical Director (Metro East Area, IL) at Positive Development, according to the company’s current public directory. The company publishes the credentials MA, CCC-SLP. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Susan Smith-Foley is Clinical Director (Cherry Hill, NJ; Lakewood, NJ) at Positive Development, according to the company’s current public directory. The company publishes the credentials OTD, MPA, OTR/L. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Growth investor at Mobeus and former Beringea chief investment officer.

Independent investment-committee chair with private-equity and venture-capital experience.

Design and social-impact adviser who co-founded accessible-navigation company Wayfindr.

Enterprise technology leader experienced in sales, commercial strategy and growth.

Product designer supporting founders with prototyping, development and product launches.

Revenue and go-to-market specialist supporting seed and Series A companies.

Media and technology strategy professional with executive and nonexecutive board experience.

Mental-health social worker and S12 Solutions co-founder; supports health innovation.

Founder-selection and fund-operations specialist with corporate innovation experience.

Investor-relations and operations professional formerly at IBM and Octopus Ventures.

BGV co-founder and CEO; previously founded School of Everything.

Startup-support specialist working on fundraising, product testing and portfolio development.

Early-stage investor experienced in commercial growth, fundraising and impact strategy.

Impact-investing and founder-origination professional with ESG and human-rights experience.

Finance and fund-valuation specialist, previously at Deliveroo and EY.

Par Equity founding partner and investment-committee member; also a PXN Group partner.

Alexandra Smith is Clinical Director (Broken Arrow, OK; Tulsa, OK) at Positive Development, according to the company’s current public directory. The company publishes the credentials MS, OTR/L. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Ben Russell is Clinical Director (Long Beach, CA; Whittier, CA) at Positive Development, according to the company’s current public directory. The company publishes the credentials PsyD. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Lina Moyano is Clinical Director (Fort Lauderdale, FL) at Positive Development, according to the company’s current public directory. The company publishes the credentials EdD, LCSW. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Liesl Hartmann is Clinical Director (Bethesda, MD; Capitol Hill, DC; Merrifield, VA) at Positive Development, according to the company’s current public directory. The company publishes the credentials MA, CCC-SLP, BCS-CL. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Cindy Davis is Clinical Director (Culver City, CA; Northridge, CA; Pasadena, CA) at Positive Development, according to the company’s current public directory. The company publishes the credentials PhD. The company provides developmental relationship-based autism care integrating clinical disciplines and family support. A longer individual biography is not published in this directory.

Ryan Park is named among LVIS’s public company employee listings, with the company’s own directory linking his exact professional profile at ryan-investor. This establishes the published LVIS affiliation; the accessible primary material does not establish his exact operating position, board capacity, educational history or appointment dates. No investment-manager role or personal investment is inferred from his profile slug. Other RyanPark namesakes remain distinct.

Samuel Lee is a publicly listed LVIS team member, confirmed by the company’s own employee directory and his exact self-authored professional profile. His profile identifies Alameda, California and the University of California,Davis, and describes professional learning in AI-assisted financial forecasting and MicrosoftCopilot. The accessible primary profile does not disclose his exact LVISjob title or appointment dates; a third-party chief-financial-officer label is not imported as a confirmed current executive capacity. He is distinct from similarly named finance, recruiting and software professionals at other employers.

Bill Antilla is a healthcare executive with a current publicly disclosed LVIS affiliation in Palo Alto. His own profile describes a background in neurology and sleep-diagnostic medical devices, including EEG, polysomnography and ambulatory EEG product development. The primary2023 FDAK222450 record names WilliamAntilla as LVIS’s applicant contact, distinguished from external consultant Veranex correspondent ZaneLiu. His current accessible profile confirms LVIS but does not expose his exact executive title; third-party product-strategy titles are not substituted as current primary evidence. His public projects include EasyAmbulatory2 and EasyII/III EEG systems developed before the current LVIS product.

Sweta Srivastava is LVISCorporation’s head of regulatory affairs, explicitly named as the applicant contact in the primary NeuroMatch K241390 and K250239 FDA510(k) summaries. Her own current public profile and LVIS’s own employee directory corroborate the company affiliation. Her public professional background includes medical-device regulatory strategy, quality and healthcare consulting; she studied at the University of Southern California and holds Regulatory Affairs Certification for devices from RAPS, issued in2024. Exact company appointment dates are undisclosed. She is distinguished from unrelated educators and similarly named professionals.

Jin Hyung Lee is the founder of LVIS Corporation, which her company states she established in Palo Alto in2013. She is an associate professor of neurology and neurological sciences, neurosurgery and bioengineering at Stanford, with a courtesy appointment in electrical engineering. Her laboratory develops interdisciplinary methods to analyse, visualise and control systems-level neural circuits using biology, engineering, imaging and signal processing. She holds an electrical engineering bachelor’s degree from Seoul National University and master’s and doctoral degrees from Stanford, completing the PhD in2004. Stanford lists her NIHDirector’s Pioneer Award in2019. SKNetworks’2022 primary announcement also identified her as LVISCEO; the current company website confirms founder capacity without a complete executive roster. Her academic research awards are distinct from corporate fundraising.

Kaitlyn (Kait) Tregenza is named as an adviser on Emmeline Ventures’ current website. Its biography describes early-stage venture experience across several countries, climate and sustainability work, and a current focus on women’s and sexual health. An exact appointment date or specific investment vehicle is undisclosed.

Senofer Mendoza is an adviser to Emmeline Ventures according to its current public directory. The issuer biography also identifies her as a founder and general partner of Mendoza Ventures, focused on fintech, artificial intelligence and cybersecurity. Her outside manager role does not imply an Emmeline fund allocation, personal portfolio check or LP investment.

Gary Fraser is named as an adviser on Emmeline Ventures’ current website. Its biography describes MBA-program leadership at UCLA Anderson, adjunct teaching at NYU Stern and previous brand-management work. It identifies a University of Pennsylvania EdD. These outside academic affiliations are distinct from employment at the venture manager.

Naseem Sayani co-founded Emmeline Ventures and formerly served as a general partner. The current firm website labels her Co-Founder, while the 2026 UCSF RISE UP speaker biography describes her Emmeline founding-partner role in the past tense and the September2026 first-hand interview explicitly calls her a previous GP. That interview identifies current GCWC and GCWC Capital founder/CEO work. Current Emmeline GP status and an exact departure day are not inferred from older team biographies or SEC filings.

Azin Radsan van Alebeek co-founded Emmeline Ventures and is a current general partner. Her company biography describes executive, board-advisory and educational work across the United States and Europe, with an interest in women’s financial independence. The July2025 Fund I SEC filing names Azin van Alebeek as an executive officer.

Methinks’ current team page identifies him as Senior Finance Manager in a named employee testimonial. He says he joined the company in January 2023 after consulting for European technology startups.

Marc Ribó is named on Anaconda Biomed’s current public scientific advisory board. The issuer describes the clinician’s external clinical affiliation as Assistant Professor Stroke Unit. Department of Neurology Neurologist. Hospital Vall d’Hebron. Barcelona Professor of Neurology at U.A.B Editor, Interventional Neurology Journal. This is an advisory relationship rather than company employment.

Tudor Jovin is named on Anaconda Biomed’s current public scientific advisory board. The issuer describes the clinician’s external clinical affiliation as Medical Director, Neuroscience Service Line, Professor and Chair, Department of Neurology, Cooper University Health Care, Camden, New Jersey. Past President, Society of Vascular and Interventional Neurology (SVIN). This is an advisory relationship rather than company employment.

Stephanie Greer co-founded Akin Mental Health and held Doro Mind’s Director of Product Management role when announcing Akin’s integration in2024. The current company’s public2026 farewell states she has departed to train as a marriage and family therapist, so this role is historical. Her older Akin biography describes a neuroscience doctorate at Berkeley and digital-health product work at Apple and Hopelab.

Brady Richards co-founded Doro Mind, drawing on healthcare software-building experience and family experience of serious mental illness. The company publishes him alongside Mimi Liu as co-CEO. SEC filings also name Francis Brady Richards as an executive officer and director.

Mimi Liu co-founded Doro Mind to improve family support and continuity of care for people living with serious mental illness. Her published founder story describes lived family experience guiding the company’s approach.

Dr. John Mackenzie, DNP, MAOL, FNP, RN, a retired member of the Armed Forces, is a nurse practitioner at Doro Mind, where he brings decades of leadership in behavioral health as a psychiatric nurse, supervisor, and interim inpatient director. Doro Mind’s terms distinguish clinical-provider services from the company’s support platform; a published provider-team affiliation does not establish payroll employment.

Dr. Shayna Feuer, DNP, MSN, RN is a nurse practitioner at Doro Mind, where she brings her experience as a board-certified psychiatric nurse practitioner specializing in integrative, evidence-based care for individuals across the lifespan. Doro Mind’s terms distinguish clinical-provider services from the company’s support platform; a published provider-team affiliation does not establish payroll employment.

Clare Jibb, MSN, PMHNP-BC is a nurse practitioner at Doro Mind, where she brings decades of experience in psychiatric care, both in the U.S. and the U.K., to her work with individuals and families facing serious mental illness. Doro Mind’s terms distinguish clinical-provider services from the company’s support platform; a published provider-team affiliation does not establish payroll employment.

Dr. Hannah Bock, DNP, PMHNP-BC is the Associate Clinical Director at Doro Mind, where she leads with both clinical insight and strategic focus. As a psychiatric nurse practitioner, Hannah provides direct care to individuals and families navigating serious mental illness, combining deep empathy with medical precision. Doro Mind’s terms distinguish clinical-provider services from the company’s support platform; a published provider-team affiliation does not establish payroll employment.

Dr. Robert Laitman is a pioneering physician in psychiatric internal medicine and the Founding Clinical Director at Doro Mind. He is nationally recognized for his leadership in treating serious mental illness with evidence-based, compassionate care, shaped by both decades of clinical expertise and his lived experience as a father of a son diagnosed with schizophrenia. Doro Mind’s terms distinguish clinical-provider services from the company’s support platform; a published provider-team affiliation does not establish payroll employment.

La Keisha Landrum Pierre co-founded Emmeline Ventures and is a current general partner. Her company biography describes international operating leadership and previous CEO, COO and chairwoman roles at a media company. Emmeline Ventures Fund I’s July2025 SEC filing lists La Keisha Pierre as an executive officer, supporting the same founder identity.

Insight Partners source, reviewed October 8, 2026: Teddie Wardi joined Insight in 2017, sits on the firm's Investment Committee, and leads a team focused on early-growth investments in fast-growing software businesses. His investments include Wiz (acquired by Google), Armis Security, Hinge Health, SentinelOne, Atlan, Island, Cognigy, Docker, and many others. Previously, Teddie was a Partner at Atomico, a major European venture fund, where he led growth investments in SaaS companies. Prior to Atomico, he was with Dawn Capital, focusing on early-stage SaaS investments. Earlier in his career, Teddie co-founded Nervogrid, a cloud marketplace platform acquired by ALSO Group. Teddie holds an MBA from Harvard Business School and a B.Sc. from Aalto University in Helsinki.

Adviser with international business-development and corporate-finance experience, including public listings and mergers and acquisitions.

Experienced in research-based intellectual property, business development, licensing, trade sales and company turnarounds.

Finance adviser with experience in financial administration, strategy, organizational development and mergers and acquisitions.

Consultant overseeing regulatory compliance and governance, with a background in investment banking and asset management.

Life-sciences researcher and technology-transfer specialist with experience in medical incubation and research-based investment sourcing.

Applied physicist with research, engineering and international software-business management experience.

Pharmacologist with preclinical and clinical drug-development experience and a background commercializing biotechnology projects.

Finance executive experienced in commercialization, restructuring, mergers and acquisitions, including previous roles at NORCE, TTS and EY.

Mechanical engineer and financial analyst with experience leading technology companies and serving on portfolio boards.

Experienced in business development, corporate finance, investment management and leading research-funding foundations.

Kaj-Gustaf Johan Bergh is a registered chairman of the board of Harjavalta Ventures Oy, the early-stage investment subsidiary of Finland’s Harjavalta Group. The official current Finnish trade-register extract identifies this subsidiary governance appointment; the parent group publishes the same person in its own governance and contact directory. This board affiliation does not establish subsidiary employment or an executive investment-management title.

Elina Annikki Aine-Simonen is a registered board member of Harjavalta Ventures Oy, the early-stage investment subsidiary of Finland’s Harjavalta Group. The official current Finnish trade-register extract identifies this subsidiary governance appointment; the parent group publishes the same person in its own governance and contact directory. This board affiliation does not establish subsidiary employment or an executive investment-management title.

Anna-Karoliina Aine is a registered board member of Harjavalta Ventures Oy, the early-stage investment subsidiary of Finland’s Harjavalta Group. The official current Finnish trade-register extract identifies this subsidiary governance appointment; the parent group publishes the same person in its own governance and contact directory. This board affiliation does not establish subsidiary employment or an executive investment-management title.

Jussi Aimo Samuli Aine is a registered board member of Harjavalta Ventures Oy, the early-stage investment subsidiary of Finland’s Harjavalta Group. The official current Finnish trade-register extract identifies this subsidiary governance appointment; the parent group publishes the same person in its own governance and contact directory. This board affiliation does not establish subsidiary employment or an executive investment-management title.

Tadas Gudauskas is FIRSTPICK’s head of platform. Earlier experience includes Invest Lithuania and the Lithuanian Embassy in India, where he worked on Lithuania’s business proposition in Bangalore. He now builds the networks, practical support and shared knowledge available to portfolio founders.

Rūta Sičiūnaitė is an investment analyst at FIRSTPICK. Her background includes strategy, finance and market analysis at Civitta and PwC and work at a software startup on planning, go-to-market strategy and finance. She researches prospective founders and develops investment cases with the firm’s partners.

Nikodemas Valiušaitis is FIRSTPICK’s finance and compliance associate. He studied economics at Vilnius University and Ryukoku University in Japan, and previously worked in technology sales, financial modelling and product implementation. He supports the manager’s legal processes and fund operations, bringing an analytical approach to venture finance.

Marijus Andrijauskas is a FIRSTPICK general partner and co-founder with international software-business management, strategy, sales, marketing and operating experience. He founded technology businesses including Teamgate and later worked with a large accelerator portfolio. He mentors FIRSTPICK founders on strategy, fundraising, investor presentations and business planning.

Andra Bagdonaitė is a FIRSTPICK general partner and co-founder. Her experience spans entrepreneurship and coding education, consulting at Civitta, and investment management at Startup Wise Guys. At FIRSTPICK she leads investments, brand and limited-partner engagement while supporting founders from the earliest stages.

Dmitrij Sosunov is FIRSTPICK’s managing partner and a co-founder. He has entrepreneurial experience across businesses that failed and exited, followed by management consulting in business development, coaching, operations and leadership. He previously managed a fund with Jonė Vaitulevičiūtė and advises FIRSTPICK founders on product-market fit, sales and strategy.

Jonė Vaitulevičiūtė is a general partner and co-founder of FIRSTPICK. Her career includes IBM, startup advisory work at Civitta and Startup Division, and managing a venture fund under Startup Wise Guys before FIRSTPICK. She supports fundraising, strategy and metrics, with interests in marketplaces, wellness technology and fintech.

Insect breeding specialist named as a co-founder in the company’s own team publication.

Entrepreneur with experience in enterprise sales, fundraising and scaling companies.

Insect breeding and process development entrepreneur.

R&D leader with a University of Rhode Island PhD and experience at Arch Therapeutics, Medtronic, Biolink and C.R. Bard.

Medical device and biotech operator with previous leadership roles at Becton Dickinson.

Physicist working on micro/nanofabrication and drug delivery, previously affiliated with Tufts and Harvard-MIT.

Electrical and computer engineer educated at NTUA and Tufts University.

Biomedical engineer with degrees from Union College and Tufts University.

Former LucasArts creative director and engineer identified in Akili’s2022 prospectus among the founding contributors who developed its video-game therapeutic technology. Historical founder affiliation; current operating role unverified.

Akili co-founder and former LucasArts executive art director, identified in its2022 securities prospectus as helping translate early cognitive-neuroscience research into video-game therapeutic technology. Historical founder affiliation; no current executive title inferred.

Virtual Therapeutics finance and operations executive who became Akili’s treasurer and secretary on July2,2024 following the acquisition. Last-confirmed legal appointment is distinguished from an unverified current operating title. The May31,2024 parent tender identifies him as Virtual Therapeutics Vice President Operations and Finance. He served as Director Business Management for Microsoft Game Studios’ Turn10 and Playground Games2019–2021 and previously held Xbox third-party gaming-finance roles2008–2019, most recently Group Finance Manager. He has a BS in Finance from Brigham Young University and an MBA from the University of Washington. No authenticated original portrait was verified in retrieved parent sources.

Daniel (Dan) J. Elenbaas became Akili’s sole director and president on July2,2024 following acquisition by Virtual Therapeutics, where he was co-founder and CEO. The SEC closing filing establishes the appointment; no later public officer roster has been verified. Primary May31,2024 parent tender identifies him as Virtual Therapeutics president, CEO and director since its founding in2015, retaining majority shareholder control after institutional minority financing. He founded and led Clearshift2012–2017 and Amaze Entertainment1996–2007, and served on Foundation9 Entertainment’s board2007–2016. He earned a BA in Political Science at Brigham Young University. His native vthera.com DanE.png portrait matches the company’s named Dan Elenbaas card; last-confirmed parent governance is distinguished from an unpublished current full roster.

Veteran game designer and former Google chief game designer appointed Akili executive advisor in2017. Earlier games experience includes Lucasfilm,3DO and DreamWorks; current advisory status is unverified.

Former DreamWorks Interactive CEO and Electronic Arts technology/visual executive appointed Akili executive advisor in2017. Co-founded Pacific Data Images and worked with Vanedge Capital; current Akili advisory status is unverified.

Former Cubist CEO and Biogen CNS commercial leader appointed Akili executive chair in2017. Founded Life Science Cares; later Akili board chairs are documented separately. Historical role only.

Former Merck research executive and University of Washington biochemistry chair named to Akili’s clinical advisory committee November2018. This is a dated historical scientific-advisory affiliation.

Psychiatrist and eMindScience founder named to Akili’s clinical advisory committee in November2018. The source described an East Carolina University psychiatry affiliation; current committee service is unverified.

Biogen executive named to Akili’s clinical advisory committee in November2018; this advisory affiliation is dated and current service is unverified.

PureTech executive and Akili private-company director named as an existing director in its July2022 public-board nomination release. Nomination did not by itself establish a later public-company seat; that appointment remains unverified. PureTech’s primary announcements identify his CEO appointment April9,2024 and departure from CEO and board roles July16,2025. This is a historical PureTech affiliation; his existing Akili role and image are preserved. PureTech’s2022 annual-report biography subsequently confirms actual Akili director service November2017–September2019 and June2021–October2022, superseding the earlier nominee-only uncertainty. Exact appointment/resignation days are unpublished.

Akili director associated with JAZZ Venture Partners, listed in the July2024 acquisition filing among all resigning public directors. Historical corporate governance is not an inferred personal cash check.

Social Capital founder and chairman of Akili’s public board following the2022 SPAC transaction. Akili’s October6,2023 leadership-transition letter confirms he left the board when Eddie Martucci became chair. Board membership does not establish an individual investment. Founder of Social Capital in 2011 and current CEO of its legal adviser The Social+Capital Partnership LLC, verified by March31,2026 ADV and the current own-site disclosures. He previously led growth and platform work at Facebook after roles at Mayfield, AOL and Winamp. His investment platform distinguishes historical external venture funds from proprietary permanent capital. His June29,2026 own 8090 announcement also confirms he became the AI software company’s CEO, a separate operating affiliation rather than a new manager cash raise.

Named in Akili’s2022 public board and described as UnitedHealth Group’s former chief scientific officer. This is a historical confirmed board affiliation, not a current post-acquisition director assertion.

William (BJ) Jones Jr served on Akili’s public-company board and resigned July2,2024 at the acquisition. Akili’s2022 biography identified his commercial leadership at Biohaven and earlier Takeda experience; outside-company titles are historical source descriptions.

Akili director and audit-committee chair appointed October25,2022; resigned July2,2024 when Virtual Therapeutics acquired Akili. Earlier CFO experience includes PayPal, CBS Interactive and YapStone.

Appointed Akili chief marketing officer October7,2020, following women’s-health leadership at AMAG and marketing/customer-experience work at Boehringer Ingelheim. This is a dated historical appointment, not a verified current company role.

Appointed Akili chief financial officer in April2019. Previous finance leadership included Vertex Pharmaceuticals, Capgemini and Texas Instruments; graduate study at MIT/Sloan and the University of Massachusetts Amherst. Historical appointment retained, with current post-acquisition employment unverified.

W. Edward (Eddie) Martucci II is an Akili co-founder who helped establish the company through PureTech in2011. Served as CEO until his October6,2023 transition to board chair; resigned from the board July2,2024 at the acquisition. Holds Providence College biochemistry and Yale molecular-biophysics/biochemistry degrees.

Published Akili vice president of marketing and communications with healthcare and consumer-marketing experience. Previously helped launch diagnostic technologies at PathAI and Foundation Medicine. Current post-acquisition employment is not established by the surviving company biography.

Published Akili chief legal officer and general counsel, first appointed to its leadership in April2019. Earlier legal and compliance roles include IDEXX, Blue Health Intelligence, Allscripts and GE Healthcare; holds Purdue and Columbia Law degrees. Post-acquisition operating status is unverified.

Akili’s published chief product officer, appointed March17,2022. Earlier games-industry work included Glu Mobile, founding Taunt, PopCap/EA and Microsoft Xbox Live Arcade. Surviving company bio is qualified because post-acquisition operating status is unverified.

Clinical psychologist and published former-era Akili chief medical officer, appointed in2022 after leadership at Holmusk. Earlier spent more than twenty years at Duke and led ADHD research including Akili’s STARS trial. Studied clinical psychology at Auburn; website bio does not establish current post-acquisition employment.

Akili scientific co-founder and published chief scientific advisor, formerly an Akili director until July2,2024. UCSF Neuroscape founding director and cognitive-neuroscience researcher studying attention, memory, distraction and cognitive aging with neurophysiological methods. His Akili scientific biography remains publicly accessible; post-acquisition operating/advisory status is unverified.

Kiki Hooton runs community and events for Howdy Partners, including its Founders Summit and Pitch Series. Her background spans environmental technology and sustainability. She also serves as program and membership director at Local First in Southwest Colorado.

Jamie Finney is a founder and venture partner of Howdy Partners, focusing on investment and finance operations. His earlier work includes Startup Colorado and Kokopelli Capital. Based in Durango, he also writes about capital and equitable entrepreneurship.

Marc Nager is a founder and managing partner of Howdy Partners. He co-founded and formerly led Startup Weekend and UP Global, then served as Techstars chief community officer and managing director of Telluride Venture Accelerator. He lives in Durango.

Cory Finney co-founded Greater Colorado Venture Fund, now Howdy Partners, in 2018 and is a managing partner. A Durango-based entrepreneur, he previously co-founded and led SnowGate through acquisition, served as an entrepreneur-in-residence at Boomtown and co-founded Kokopelli Capital.

Matthew (Matt) Franklin was appointed Akili CEO in October2023 after joining as president and COO in2022. Earlier roles included Exact Sciences precision oncology, Thrive Earlier Detection, ArcherDX, Foundation Medicine and Boston Scientific; studied at Northwestern and Michigan. He is distinct from SoundBlade Medical’s chief financial officer Matt Franklin. Akili’s public board seat ended July2,2024; the surviving website bio is not proof of current post-acquisition executive employment.

Sree N. Koneru is a medical technology professional who publicly announced joining Echo Neurotechnologies after his work at Viant Medical. He describes experience leading complex neurotechnology programmes from concept to clinical development and working at the intersection of engineering, neuroscience and clinically driven device development. His accessible public profile discusses a prior director of programme management role at Viant, but no equivalent current Echo executive title is inferred. Published work covers electroceuticals, RF fields and neuromodulation; prior products and approvals belong to their respective developers, not automatically Echo.

Robert Gaffney publicly identifies a current professional affiliation with Echo Neurotechnologies in the San Francisco Bay Area. His own accessible profile also identifies Pepperdine University’s Graziadio School of Business and Management. The accessible first-party profile does not disclose his exact Echo position, so no chief executive, operations or director title is inferred. His affiliation is preserved as published without treating social reactions, unrelated namesakes or prior-company connections as evidence of new investment.

Rico Severa is a senior accounting manager at Echo Neurotechnologies, confirmed by his own public appointment announcement. He describes specialist biotechnology accounting experience and full-cycle accounting work. His public education includes Chapman University, with data analytics and business studies, and his earlier experience includes BioMarin Pharmaceutical. His Google Data Analytics qualification supports his analytical finance background. The exact appointment day is not inferred from relative social-post timestamps.

Philip A. Starr is an external consultant to Echo Neurotechnologies, as disclosed in a2026 scientific publication, and a UCSF neurosurgeon specialising in movement disorders and implanted neurostimulation. He is a professor of neurological surgery and holds the Dolores Cakebread Chair. His research investigates motor-network physiology and adaptive deep brain stimulation using chronically implanted bidirectional interfaces. He earned his medical degree at Harvard, completed neurosurgery training at Brigham and Women’s Hospital and a movement-disorders fellowship at Emory. The consulting relationship is distinct from employment, board membership or an equity investment; academic and clinical grants are not Echo company cash.

Kenneth H. Louie is a neuroscience researcher and an employee of Echo Neurotechnologies, explicitly disclosed in his2026 Nature Medicine publication on adaptive deep brain stimulation for gait control in Parkinson’s disease. His earlier academic affiliations include biomedical engineering at the University of Minnesota and neurological surgery at UCSF. His research examines neural signals, gait and closed-loop neuromodulation. The published trial was completed before his Echo employment and states that Echo had no role in its design, data collection, analysis or publication. His exact current company title is undisclosed. He is distinct from similarly named Amazon product managers, dentists and economists.

David A. Moses is a scientist working on neural decoding and speech neuroprostheses, and an assistant professor of neurological surgery at UCSF. A primary2025 Nature Neuroscience publication explicitly discloses that he is a director at Echo Neurotechnologies; it does not establish whether this is a board or functional executive title, so that capacity remains qualified. His research includes machine-learning methods that translate neural activity into communication for people with paralysis. UCSF identifies his doctoral work and subsequent postdoctoral research in Edward Chang’s laboratory. His academic research and patents do not independently establish corporate investment tickets.

Edward F. Chang is a co-founder of Echo Neurotechnologies, independently disclosed by UCSF and his published scientific work. He is a neurosurgeon and UCSF’s Joan and Sanford Weill Chair of Neurological Surgery, specialising in brain mapping, speech and motor preservation, epilepsy and implantable neurotechnology. His research examines neural mechanisms of speech, movement and emotion, and he co-directs the UCSF/UC Berkeley Center for Neural Engineering and Prostheses. He earned his medical degree and completed neurosurgery training at UCSF, following chemistry studies at Amherst. He was elected to the National Academies of Medicine and Sciences in2020 and2025. Academic research funding and experimental clinical results are distinct from Echo corporate financing and market approval.

Samantha Meadows, LCSW, is explicitly identified as a Flowly pain coach and licensed therapist in the company’s published articles on therapy and loneliness. She discusses therapeutic relationships, emotional resilience and the biopsychosocial dimensions of pain. The published affiliation is verified, but a complete current staff tenure and an authentic exact-person portrait remain unverified. Unrelated political candidates and other name matches are excluded.

Lauren Flynn, PhD, is Flowly’s published lead therapist. The company describes her work in pain psychology, initial evaluations and matching patients with licensed therapists or pain coaches within its therapist-led program. Her authentic portrait appears on the company’s named lead-therapist page. Program outcome figures on that page are company claims, not independently established universal results. She is distinct from the professional football player with the same name.

Julien Soros is co-founder and chief technology officer of Flowly. He studied electrical engineering at Yale with a focus on control systems and digital signal processing. His prior engineering work at Hyperloop One involved control algorithms and system stability analysis; earlier guitar-building experience informed his interest in engineering.

Narae Kim is co-founder and chief creative officer of Flowly. Her professional work spans art and creative direction in virtual reality, film, theatre and entertainment, with projects presented at industry events and film festivals. She combines immersive content design with the company’s relaxation and biofeedback experiences.

Celine Tien is co-founder and CEO of Flowly. She leads its virtual pain and anxiety platform and is the contact principal investigator named in NIH’s R44DA049630 research award. Her background includes immersive filmmaking and work in animation development. Founder and clinical research roles do not imply a personal cash investment.

Paul Kedrosky is published as a General Partner at SK Ventures and is a manager of its legal management company in the April28,2026 Florida annual report. He is an investor, entrepreneur and technology writer who founded HSBC James Capel’s technology-equity research practice. His published professional background includes research and commentary on entrepreneurship, innovation and venture finance at the Kauffman Foundation and Bloomberg. He trained in engineering, finance and the economics of technology. The manager biography contains historical career details; past professional appointments are not asserted as current employment, and personal angel investments remain separate from the firm’s portfolio.

Eric Norlin founded SK Ventures in May2011 and is published by the manager as a General Partner. He is also a technology-conference entrepreneur: his work includes Digital ID World, SaaScon, Defrag and Glue. Earlier he worked in identity-technology marketing at Ping Identity and contributed technology reporting and conference content. His manager biography describes a South Asian studies undergraduate degree and earlier government technology experience. The Florida management-company registry’s April28,2026 annual report identifies him as a manager. He publicly acknowledged SK Ventures’ investment in Kamiwaza on a company executive’s joining announcement; this is institutional evidence, not a separate personal check.

Zaz Floreani joined FirstMile Ventures in summer2023 as Venture Partner and leads its Texas investing from Austin. She previously worked as Principal at Next Coast Ventures, building its pre-seed and seed investment platform, and held business-development and corporate-development roles at Mass Relevance, Spredfast and Dropoff. She holds graduate degrees from the University of Texas and a history degree from UCLA.

Aaron Stachel helped launch FirstMile Ventures with Bill Miller in 2014 and became a partner in its second fund. He invests across healthcare technology, robotics, logistics, fintech and other early-stage businesses. He previously served ten years as an Army officer and helicopter pilot, then worked in strategic finance and M&A at Newmont Mining. He studied economics at West Point and earned an MBA from Denver.

Bill Miller founded FirstMile Ventures in 2014 after operating and investing in technology companies. He co-founded StorageNetworks and served as CTO through its 2000 IPO; earlier ventures included CERAM and Krysalis. He also led enterprise-software companies XAware and Axellio. Before FirstMile he invested personally in technology startups. He studied chemistry at Illinois and began as a semiconductor process engineer, with patents in chips, memory and storage systems.

Matthew Krna, also known as Matt Krna, is founder and Managing Partner of Ladera Venture Partners, a digital health-focused investment firm. His continuing role is named in current C1 Fund governance materials and public SEC filings. He is also founder and Managing Partner of Two Meter Capital and a Venture Partner at Alpha Partners. He previously co-founded and led Princeville Global and was a partner at SoftBank Princeville, with earlier investment roles at Investor Growth Capital and Canaan Partners and investment-banking experience at Credit Suisse and Donaldson, Lufkin & Jenrette. He has served as a director or board observer at companies including Doctor on Demand, Remitly, Criteo, Dotomi and ID Analytics, and previously served as CEO of Alpha Partners Technology Merger Corp. He holds an A.B. degree from Harvard University. These other-firm investments and funds are not automatically attributed to Ladera.

Physician and healthcare investor promotedtoPartnerandEvidityManagementCommittee inownJuly5,2023release,afteroverseeinginvestment sourcingandevaluation. PriorMcKinseyhealthcareconsultant,UniversityofPennsylvaniaemergencymedicineinternship,GoldmanSachsinvestmentbankanalyst andHarvardMedicalSchoolhealthcarepolicyresearchassistant. Own2019rebrandreleasecalledhimPrincipal. Heisabsentcurrentpublishedteambio and2026foundertransitionmessage thanks himforbuildingEvidityoverthepast11years; roleisexplicitlyhistorical,exactdeparturedayunknown. Genuineownnamed2022portraitretrievedfrompublicWordPressattachmentrecord,notclaimedfresh2026photo.

JoinedEvidity in2021 accordingtoownbio; alternativeasset accounting/financeprofessional withnearlythreedecades experience andpreviousCFO roles attwolife-sciences/technologyVC firms2008–2019,plushedgefundandmultistrategyplatformfinance. Begancareerasa BDOfinancialservicesauditmanager; QueensCollegeBAAccountingandEconomics,CPAandCFA. OwncurrentEviditydirectorylistsCFO; exactjoiningdayunknown. No personalportfolioinvestment or inferredEckuityrole.

Stevie Case is published in Coalition Operators’ external operator network. Revenue exec trusted by top startups to turn trust and security into growth. Published career affiliations: Vanta, Twilio. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company. Stevie Case is a published general partner of 20SALES, focused on smb through enterprise, outbound, cs, marketing. The official fund directory highlights operating experience associated with vanta, Visa, Twilio. These career references describe expertise rather than additional inferred current employment.

Co-founded CanepaHealthcare/Evidity withPaulEnever in2014. Former McKinseyPartner in telecommunications,mediaandtechnology; prior HermesGrowthPartners cofounder wherehelaunchedtheTMTfund. Systemsengineer withStanfordMS inEngineering-EconomicSystems. OwnEviditybiography listsPoseidonMedical/PreludeDx boards andformerAkiliobserver,Biotheranostics,DuneMedical,EndoGastricSolutions affiliations. His own2026 announcement saysEviditybecomingpartofEckuity andheandPauljoining; currentEckuityteamlists himasPartner. Historicalmanagerchecksremaininstitutionalattribution,notpersonal. Alejandro Sanchez is partner at Eckuity Capital. Co-founded Evidity in 2014 and joined Eckuity as a partner in 2026. Historical Evidity and Canepa investments retain their original institutional attribution.

Shani Taylor is published in Coalition Operators’ external operator network. Go-to-market force behind the tools redefining how teams design and build together. Published career affiliations: Figma, Airtable. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Co-founded the CanepaHealthcare/Evidity investment firm with AlejandroSanchez in2014. Former McKinseyPartner with twelveyears advising biopharma,medtech,hospitals andhealthcareservices; earlier SandozR&D andMITbiotechnologyresearch. Holds a Rensselaer chemicalengineeringBS and UniversityofMinnesota chemicalengineeringPhD focusedonwoundhealing/tissueengineering. OwnEviditybio lists Augmedics,MagnoliaMedical andPoseidonMedical boards and formerCardiva,DuneMedical andStandardMolecular boards; no uncoordinatednew outsidecompanyroles orpersonalchecks are inferred. Current2026Eckuitydirectory independentlylists himasPartner and foundertransitionpostexplicitlydescribes joiningEckuity; legacyEvidityrole notexclusivecurrentoperatingclaim. Paul Enever is partner at Eckuity Capital. Co-founded Evidity in 2014 and joined Eckuity as a partner in 2026. His existing Evidity biography, portrait and institutional affiliations are preserved.

Rachel Hepworth is published in Coalition Operators’ external operator network. Brand and growth marketer behind the most iconic B2B platforms of our time. Published career affiliations: Notion, Slack, LinkedIn. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Poppy Thorpe is published in Coalition Operators’ external operator network. Brand visionary for the companies shaping categories and culture. Published career affiliations: Glossier, Snap. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as Washington Research Foundation Entrepreneurship Endowed Professor in the Paul G. Allen School of Computer Science and Department of Engineering Electrical & Computer, and Head of Health Technologies at Google. These external titles are source-qualified directory context, not additional unverified employer roles.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as CVP of Microsoft Cloud and AI, and Distinguished Engineer. These external titles are source-qualified directory context, not additional unverified employer roles.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as Founder of Kubernetes, and Founder & Former CTO of Heptio (acquired by VMware). These external titles are source-qualified directory context, not additional unverified employer roles.

Melynda Barnes is published in Coalition Operators’ external operator network. Physician and startup executive passionate about building groundbreaking patient-first experiences Published career affiliations: Ro, Weill Cornell Medicine, Yale Medicine. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as Co-founder, board director, and former CEO / CTO of ExtraHop. These external titles are source-qualified directory context, not additional unverified employer roles.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as Professor, and Bill & Melinda Gates Chair Emeritus, UW Paul G. Allen School of Computer Science & Engineering. These external titles are source-qualified directory context, not additional unverified employer roles.

Maggie Hott is published in Coalition Operators’ external operator network. Sales leader for the defining technologies of the AI and no-code eras. Published career affiliations: OpenAI, Webflow, Slack. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company. Maggie Hott is a published general partner of 20SALES, focused on plg, mid market, enterprise, solutions engineers, sales dev. The official fund directory highlights operating experience associated with Webflow, Open AI, Slack. These career references describe expertise rather than additional inferred current employment.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as Former CVP of Microsoft Azure Cloud Security & Microsoft for Startups. These external titles are source-qualified directory context, not additional unverified employer roles.

Kate Earle Jensen is published in Coalition Operators’ external operator network. Enterprise sales leader at the cutting edge of AI and financial infrastructure. Published career affiliations: Anthropic, Stripe, Google. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as CEO of AI2 (Allen Institute for Artificial Intelligence) and Professor UW Paul G. Allen School of Computer Science & Engineering. These external titles are source-qualified directory context, not additional unverified employer roles.

Heather Fernandez is published in Coalition Operators’ external operator network. Operator-turned-founder with a track record of building trust-driven software and marketplaces at scale. Published career affiliations: Solv, Atlassian, Trulia. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Caleb John works in engineering at PSL. His biography describes founding Cedar Robotics, working on AI infrastructure at Anduril and founding Pongo, a search-model infrastructure business acquired in2024. He briefly attended the University of Washington.

Gail Airasian is published in Coalition Operators’ external operator network. Operator who’s driven impact across the most innovative companies in healthcare IT. Published career affiliations: Codametrix, Flatiron Health, anthenahealth. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Malaika Brown is an executive assistant in PSL’s current directory. Her biography describes prior community-development work at the YMCA and six years as a recruiting coordination manager at Facebook. She supports people and operational relationships at PSL.

Caitlin Sowers is a product design engineer at PSL. Her biography describes joining in2025 after working on a visual AI workflow development platform at Salt AI. She works with founders and engineers on early-stage products.

Alex Ray is a PSL principal supporting existing companies and creating new ones with Greg Gottesman. His biography describes prior McKinsey business-building work, two startup founding experiences and venture experience at Oxbow Ventures. He works on accessible applications of frontier technologies including generative AI.

Andrea Leach works in administration at PSL, joining in2021. Her biography describes office-management and administrative-support responsibilities and prior work at Pike13. She studied at the University of Washington.

Annie Pearl is published in Coalition Operators’ external operator network. Product leader who has scaled iconic SaaS and AI platforms from early traction to mass adoption. Published career affiliations: Microsoft, Calendly, Glassdoor, Box. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Matt Wang is a principal in PSL’s current directory. His biography describes joining in2021 and earlier project-lead/chief-of-staff responsibilities supporting Greg Gottesman. He previously worked at Boston Consulting Group, DoorDash and Innosight and studied philosophy at the University of Chicago.

Jaclyn Rice Nelson is co-founder and part-time gp at Coalition Operators. Jaclyn is the co-founder and CEO of Tribe AI, a startup powering the enterprise AI wave. Jaclyn has a multi-faceted view of the AI platform shift: the build versus buy decisions of her enterprise customers, the speed of innovation at the top AI platforms Tribe builds on; and the interests of Tribe’s network of 600+ top AI engineers. In addition to backing AI startups at Coalition, she helps founders across categories think through how to leverage AI to build better products, power their companies, and rethink team building. Outside company titles are attributed to the firm’s published biography, not automatically changed on external organizations.

T.A. McCann is a current PSL venture partner and technology entrepreneur. His biography describes founding Senosis, Gist and Rival IQ, earlier work at Microsoft and entrepreneurial roles at Polaris, Vulcan and Providence Health Services. Published angel-investing references are not automatically attributed as PSL fund investments.

Lindsay Ullman is co-founder and part-time gp at Coalition Operators. Lindsay has built and backed companies from every angle—as a founder, investor, buyer, incubator, and product leader. She started Umbrella, a community marketplace for seniors (acquired by IAC), and now leads product for Angi. Before that, she was a partner at GV and a company builder at Sidewalk Labs. Lindsay is the ultimate dealmaker and negotiator. She works closely with Coalition founders on fundraising, product strategy, and loves nothing more than helping them puzzle through a tough business decision. Outside company titles are attributed to the firm’s published biography, not automatically changed on external organizations.

Geoff Entress is listed as a venture partner on the current PSL directory. His biography retains the earlier managing-director/co-founder wording; the official2026 adviser filing separately identifies him as managing director/member of Pioneer Square Investment Advisor. Those unit-specific roles are retained with sources rather than assuming identical titles across the studio and fund.

Ben Gilbert is a PSL venture partner and co-founder/co-host of Acquired. His biography describes prior independent software development and Microsoft product work, including Office for iPad and The Garage. He studied computer science and engineering at Ohio State.

Julie Sandler is a current PSL venture partner and co-founder of PSL Ventures. Her biography describes her earlier tenure as general partner/managing director and prior work at Madrona. She focuses on early-stage Pacific Northwest technology companies; her historical leadership title is distinct from her current venture-partner role.

Ashley Mayer is co-founder and full-time gp at Coalition Operators. Ashley is our full-time leader at Coalition. Her first career chapter was in communications, where she helped visionary founders craft stories that shaped their companies’ trajectories. She led comms at Box from early days through IPO, was the first marketing partner at Social Capital, and helped scale Glossier from a cult beauty brand to a household name. Building a startup is all about crafting and selling a story about what the future should be. Ashley backs founders across categories, and partners with them to make sure their stories reach and resonate with their most important audiences. Outside company titles are attributed to the firm’s published biography, not automatically changed on external organizations.

David Zager is a partner at Pioneer Square Labs, leading product, visual and business design since its2015 founding. His biography describes supporting studio concepts and portfolio companies, with board responsibilities at Dance Church and Official AI. He studied visual communication at the University of Washington.

Palvi Mehta leads finance and operations as PSL’s operating partner and CFO. She previously served as CFO at ExtraHop, NewPath Networks and RadioFrame Networks and began her career at Ernst & Young. The official2026 adviser filing identifies her as CFO of Pioneer Square Investment Advisor.

Greg Gottesman is a co-founder and managing director of Pioneer Square Labs. He previously spent20 years as a managing director at Madrona and co-founded Rover. His published PSL biography describes current investment and board responsibilities and teaching entrepreneurship at the University of Washington.

Experienced in administrative support, cultural management and event coordination.

Supports investment sourcing and financial modelling, with experience in banking, mergers and acquisitions and investing.

Background in finance, investment banking, management consulting and private equity; evaluates investment opportunities.

Experienced in international finance, investment banking, company evaluation and board service.

Reviews investments and supports portfolio companies with strategic planning and fundraising; background in corporate finance.

Finance executive who became deputy CEO in 2021 and CEO in spring 2026, after serving on subsidiary boards.

Serial entrepreneur who built Picosun into an international atomic-layer-deposition business before transforming Stephen Industries into a single-family office.

Former Google and Netflix executive and founder of augmented-reality platform Poplar.

Founded MelloVR and later worked at the investor CRM company Höpöhöpo.

Previously led Nordic XR Startups and worked on Finland’s XR ecosystem at Business Finland.

Former investor at HTC Vive X and Seedcamp, and an early SoundCloud team member.

Lucas Scherdel is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Managing Director, DayOne. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Julia Schaft is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Managing Director at BioRN. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Yolanda Puiggrós Jiménez de Anta is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Partner at PwC Tax & Legal Spain. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Alexandra Prieux is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Director of Development for Alcen. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Jorge Pimenta is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Innovation Director, IPN – Instituto Pedro Nunes. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Aviv Shoher is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Supervisory Board Finance, Audit & Risk Committee Chairman, Managing Partner, IMed Capital. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Ariane Galaup Paci is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Supervisory Board Executive Committee Chairwoman, Director for Research, Leem. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Chad Floe is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Chairman of the Supervisory Board, Senior Advisor at TVM Capital Healthcare and deNovo Corporate Advisors. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Alexandra Celani-Betz is listed by EIT Health as Director of Finance and Risk. EIT Health’s governance disclosure places the management board in charge of day-to-day operations and strategic leadership. Exact appointment dates and a detailed individual career biography are not published on this directory.

Ali Neary is listed by EIT Health as Director of Communications and Corporate Affairs. EIT Health’s governance disclosure places the management board in charge of day-to-day operations and strategic leadership. Exact appointment dates and a detailed individual career biography are not published on this directory.

Séverine Lacharme is listed by EIT Health as Operations Director. EIT Health’s governance disclosure places the management board in charge of day-to-day operations and strategic leadership. Exact appointment dates and a detailed individual career biography are not published on this directory.

Graham Armitage is listed by EIT Health as Director of Community and Stakeholder Engagement. EIT Health’s governance disclosure places the management board in charge of day-to-day operations and strategic leadership. Exact appointment dates and a detailed individual career biography are not published on this directory.

Céline Carrera is listed by EIT Health as Interim CEO and Director of Programmes & Delivery. EIT Health’s governance disclosure places the management board in charge of day-to-day operations and strategic leadership. Exact appointment dates and a detailed individual career biography are not published on this directory.

Alejandro Corbellini, PhD, is a computer scientist and systems engineer whose professional profile names Applied Cognition. The January 2026 Nature Communications paper and March 2026 preprint explicitly identify his Applied Cognition affiliation. He studied computer science at UNICEN and has worked on distributed systems, recommendation algorithms and graph processing. His authentic portrait comes from his named former-personnel entry at UNICEN’s ISISTAN; that archival image is low resolution and is not represented as a newly taken photograph.

Tarandeep Singh is a research author explicitly affiliated with Applied Cognition Inc. in the company’s May 2025 Nature Biomedical Engineering and January 2026 Nature Communications papers. The 2025 author contribution statement credits him with data collection and management, formal analysis and experimental research. The publication affiliation is verified; a current formal employment title and an authentic portrait have not been independently established. Unrelated people with the same name are excluded.

Laurent Giovangrandi, PhD, is an Applied Cognition scientist and engineer working on biomedical devices, algorithms and measurement of human glymphatic function. PhysioWave’s own leadership biography names him as its co-founder and as Senior Principal Scientist/Engineer at Applied Cognition, with earlier work at Triple Ring Technologies, Stanford and Malibu IQ. Applied Cognition affiliations are independently published in its 2025 and 2026 scientific papers. The portrait is PhysioWave’s authentic named photograph.

Jake Winebaum is chairman and co-founder of Applied Cognition. The current company roster publishes his leadership role, and the company’s 2025 Nature Biomedical Engineering paper identifies him as Jake J. Winebaum with an Applied Cognition affiliation. Earlier company scientific presentations also use Jacob Winebaum. His research coauthorship concerns noninvasive measurement of human glymphatic function; publication authorship and employee shareholdings are not treated as a personal cash investment.

Paul Dagum, MD, PhD, is co-founder and CEO of Applied Cognition and an entrepreneur, physician and computer scientist. He invented the company’s investigational device for noninvasive measurement of human glymphatic function and leads its work on brain clearance and neurological therapeutics. Previously he founded Mindstrong to develop digital biomarkers of cognition and mental healthcare. His American Academy of Arts and Sciences biography describes earlier venture-backed work across healthcare, cybersecurity and supply chains.

Andrew Tan is a technology investor who publicly describes his affiliation as VC at A&E Investments and co-founder at Hi Labs. His own LinkedIn profile identifies Carnegie Mellon University and a separate current affiliation with Salience Capital. In his public Nace AI announcement he identifies himself and Lip-Bu Tan as early investors through Salience Capital and A&E Investments. Exact A&E executive title and appointment date are not publicly confirmed in the accessible first-party biography. He is distinct from the Berkeley/Stanford-trained Andrew Tan associated with Tower Research Ventures and the separate Signal profile andrew-tan_1.

Former EY professional whose software company provides startup CFO services.

Operations professional formerly with Seedblink, ANIS Romania and Gecad Ventures.

Media and communications professional with experience in journalism and startup content strategy.

Technology recruitment specialist and founder of an HR consultancy.

Startup communications and marketing professional, formerly with How to Web and Pago.

Founder of 7card, later sold to Sodexo; invests across multiple industries.

Former UiPath Head of Growth with experience scaling enterprise software marketing.

AI entrepreneur whose startup MorphL was acquired by Algolia in 2021.

Systems-engineering graduate, Romanian Space Initiative member and student pilot.

Startup investment professional with prior Renderro business-development and Techstars community experience.

Product leader experienced in developing SaaS and digital products across international markets.

Venture investor and How to Web founder; previously founded Conectoo.

Venture and finance professional, formerly at Relay Ventures and CFO of Tools For Brokers.

Finance and business-strategy professional, ACET CEO since 2017, and prior manager of ACET Capital funds.

Engineering-physics specialist in quantum chemistry and nanomaterials; previously commercialized deep technology at Anyon Systems.

Quantum-computing PhD with prior outreach leadership at Waterloo IQC and quantum-safe cybersecurity product experience at ISARA.

Named Health Innovation FundI supervisory-board member representing Achmea in the manager’s own public roster. Achmea’s original July2021 fund-introduction presentation names her FundManager and includes the authentic individually labeled portrait. This photograph and outside title are historical2021 source material, not an assertion of current2026 Achmea operating status. The current legacy-fund roster remains directly evidenced.

Named supervisory-board member of Health Innovation FundsI andII, with Mediq shown as the representing institution in Health Innovations’ own published roster. The public roster does not supply joining/end dates or a current personal biography. This fund affiliation is source-qualified; outside current same-name roles are not silently used to refresh the historical Mediq affiliation. No authentic individually named photo was verified; the current Dutchmed named card uses a generic user-placeholder and is deliberately not imported.

Named Health Innovation FundII supervisory-board member representing VGZ in the manager’s own roster. VGZ’s May22,2026 own interview identifies her as DirectorZorgOperationsAdviesControle and discusses responsible AI use inside the insurer; its individually named originalportrait is used. These institutionalroles do not create a personal ventureinvestment.

Named supervisory-board member of Health Innovation FundsI andII representing ABNAmro in the manager’s own public roster. ABNAmro’s own current healthcare-sector page independently names him and publishes his individual portrait. Fund-supervisory roles are separately scoped and not manager statutoryboard appointments.

Named Health Innovation FundIII advisory-board member representing Menzis in the original Dutch own roster and his own professional profile. The firm’s English translation instead says OostNL; this conflicting translation is retained as a source qualification and the Dutch original is used. No unauthenticatedportrait or personal check is inferred.

Named Health Innovation FundIII advisory-board member in the Health Innovations own public roster. The firm does not identify an outside employer in that roster; additional same-name biographies and portraits are not attached without independent identity confirmation. No personal investment is inferred.

Named Health Innovation FundIII advisory-board member representing OostNL in the manager’s own public roster. OostNL publishes an individually named employee biography and authenticportrait. This source does not establish an exact joiningdate or personalportfolioinvestment.

Named Health Innovation FundIII advisory-board member representing KPNVentures in the manager’s own public Dutch roster. KPNVentures current own team calls him ManagingDirector; older2022 notices called him InvestmentDirector. This is a fund advisory appointment, not a manager statutory-directorship or personalcheck.

Healthcare investor at Health Innovations since2012 according to the own biography. Former PwC consultant and ABNAmro healthcare sector director; own public profile describes his lead work on Nightbalance, ViCentra, Aidence and Prolira. Joiningyear is known but exact day is not.

Rob Goulding is an Operating Partner at Moxxie Ventures who leads go-to-market support for its portfolio. Earlier he built mid-market sales and revenue organizations at Google and Twitter and served as a startup chief revenue officer. He helps founders identify customers, improve positioning and develop repeatable sales processes and early commercial infrastructure. His published manager biography describes these operating experiences rather than personal investment participation.

Prateek Joshi is an investor at Moxxie Ventures, which announced his appointment on April17,2023. He is an AI engineer, founder and author of thirteen books on artificial intelligence and machine learning. Previously he founded Plutoshift and worked on machine-learning products at Nvidia. His work spans computer vision, industrial automation and mobile software. At Moxxie he supports founders developing AI products and infrastructure. He hosts the Infinite Curiosity podcast and publishes writing about AI and startups.

Marie Drez is Moxxie Ventures’ Chief Financial Officer. Her published manager biography describes more than twenty years working with venture funds, including Magnify Ventures and Crosscut Ventures. She supports emerging managers with fund formation and closing processes, strategic budgets, capital tables, financial operations and automation, and advises new and aspiring general partners. These former-firm affiliations provide professional background without asserting current employment there.

Alex Roetter is a General Partner at Moxxie Ventures. An engineer and operator, he previously served as Twitter’s Senior Vice President of Engineering and led its advertising engineering organization. He later ran Kittyhawk Flyer, an electric aviation company, and worked as a test pilot. He joined Moxxie as an equal general partner in2021 and assists portfolio founders with engineering, product development, operations and cash management. His personal advising and angel-investing experience predates the firm; no personal checks are inferred as manager investments.

Katie Jacobs Stanton founded Moxxie Ventures in2019 and is its General Partner. She previously led product, marketing and market-development teams at Twitter, Google, Yahoo and Color, and served in the Obama White House and US State Department. At Moxxie she supports founders with go-to-market strategy, brand development, communications and team building. Her published manager biography describes board service at Yahoo and Vivendi and a substantial personal angel-investing history; those earlier personal investments are not automatically attributed to Moxxie. She is distinct from Katie Stanton, the finance-and-operations executive at S2G Investments.

Vivek Ladsariya is Managing Director at Pioneer Square Labs and General Partner of PSL Ventures. His prior investing experience includes SineWave Ventures and Fenox; he holds engineering and MBA degrees from Mumbai and Yale. Kamiwaza’s January2025 SEC filing names him as a director, although a current complete issuer board roster is not published.

James Urquhart joined Kamiwaza as Field CTO and Technology Evangelist in 2025. His current public self-profile states that he recently left the company following a strategy change; the exact departure day is not disclosed, so this is a former affiliation. His prior work includes VMware, Dell, Cisco and AWS, and he authored Flow Architectures.

Daniel Davenport joined Kamiwaza as Federal Field Chief Technology Officer in the August2026 leadership announcement. He brings more than two decades of experience in defense, intelligence and space technology, most recently as SAIC Deputy Chief Engineer. His issuer-linked profile is linkedin.com/in/davenportdaniel.

Joseph Infantino joined Kamiwaza as Vice President of Operations and Finance in the August2026 leadership announcement. He previously co-founded cybersecurity services company Cloudrise and served as COO through its 2024 acquisition. Earlier he led Deloitte Fusion Managed Services operations. His issuer-linked LinkedIn identity is joseph-infantino-47620266; unrelated broker and realtor namesakes are excluded.

Osama Zahid is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Advocate Health. This is an advisory or cohort network affiliation, rather than a firm employee position.

John Drake joined Kamiwaza as Chief Revenue Officer in the company’s August2026 leadership announcement. He previously led go-to-market strategy for major Amazon Web Services storage portfolios and spent more than a decade at Faction.

Julia French joined Galileo in late 2024 as its first head of platform and became a partner at the end of 2025. Her operating and investing experience spans Silicon Valley and Australia, including work with founders of Atlassian, Dropbox and WhatsApp and firms including AirTree and Sequoia. She previously served as Course Director and Senior Lecturer in the Transdisciplinary School at UTS. Her personal startup investments are distinct from Galileo manager holdings.

Hugh Stephens co-founded Galileo Ventures after founding Schedugram in 2013 and growing the bootstrapped company, later renamed Sked Social, into a platform used by more than 10,000 brands. He previously worked in management consulting and Melbourne startups, advises portfolio companies and is a Board Observer at Zendir.

James Alexander co-founded Galileo Ventures. He founded INCUBATE at the University of Sydney and expanded the startup program across five universities, helping launch more than 200 startups. He previously worked as an engineer at startups including Atlassian and is a Board Observer at Relevance AI.

Jin is a software engineer, technology leader and founder who has spent his career building technology products and teams. He was an early employee at Vend, which was acquired by Lightspeed, and has since worked across a range of startups and technology businesses, including Serato, ANZ and Basis. He is the co-founder and CTO of Journey Health, a digital health startup, and organises the Prompt Poets Society, an Auckland community focused on AI engineering and emerging technology.

Tracy is an all-rounded professional with extensive experience in project management, people & culture, and business operations. She has successfully led and supported a variety of projects across different contexts and worked across corporate, non-profit and ed-tech. Tracy is deeply passionate about diversity, equity, inclusion and sustainability, and she currently serves on the board of Tāhono Inclusive Collective Aotearoa and the APEC Voices Trust New Zealand. Before joining GD1, Tracy completed her Master of Business in Diversity Management. Her expertise lies at the intersection of people, projects, and processes, where she excels in collaborating with diverse teams to tackle complex challenges and develop innovative solutions.

Catherine has a passion for building systems; a talent for juggling multiple responsibilities and thrives on the challenge of solving difficult problems by imagining what they might look like fixed. As an owner/operator for 20 years, her business management experience was gained at the coal face where she did 'whatever it took' to ensure the success of the company, including liaising with clients in over 60 different countries; project management on high budget productions; negotiating international sponsorships, dealing with a variety of stakeholders and at all times handling the day to day of running a business. Catherine's 'specialist generalist' background is an invaluable asset to GD1 where she applies what she knows about systems, processes, policies and procedures to set the company and its portfolio companies up for success. "Operations management aims at understanding the bigger picture so that you can review, decipher and problem-solve around each roadblock with an eye on how everything you do fits into and will help achieve the company's overarching objectives while remaining compliant and on track."

Jono sits within the Investment Team, supporting the Partners across the full investment process, from sourcing through diligence, investment and post-investment. He currently holds several Board Observer roles at select GD1 portfolio companies. Prior to joining GD1, he held corporate finance and advisory roles at Grant Thornton and Westpac, and led infantry platoons as a Platoon Sergeant in the Singapore Armed Forces. JT holds a BCom from the University of Auckland and is a Chartered Accountant. Jonathan is excited to learn about new technologies and work with founders to succeed and scale their startups globally.

Doug has nearly 15 years of experience working in sales, marketing, and customer success. He provides in-the-trenches, functional Go To Market support to GD1's portfolio, empowering our companies to make smart decisions and execute successfully so they can achieve global growth. Doug specialises in helping our founders and their teams succeed post investment which is a core part of what we do here at GD1. "Venture capital attracts brave, daring and determined people - being around startups and helping them is what makes me excited about being in VC..."

As General Partner, Aaron leads the Investment Team at GD1. He has over 10 years experience in Venture Capital roles in both NZ and the UK. Before joining GD1, Aaron was an Investment Manager at NZTE where he helped NZ technology companies connect with local and international VCs. Prior to this, Aaron managed Spark NZ's Corporate VC program and held investing roles at Aspinall Capital (a $100m industrial technology fund) and WHEB Partners (a cleantech venture capital firm with €250m AUM) in the United Kingdom. Aaron holds a PhD in Chemistry and a BSc Hons (1st Class) from Victoria University of Wellington and the MacDiarmid Institute of Advanced Materials and Nanotechnology. He is passionate about supporting NZ founders in taking their technologies global to solve the world's biggest challenges.

With the ability to discover the genius in others and a passion for journeying with early stage founders, Nawaz is a respected authority in the crypto/web3 space. Since 2019, he has been an avid angel investor - investing in over 15 early stage crypto companies, including US-based. As an entrepreneur, he has been through all of the phases of successfully starting a company - ideating, coming up with a product proposition, executing on that vision, and selling. His current focus at GD1 is on raising and investing for the Web3 Fund, meeting founders who are leveraging crypto/web3 tech to build new and exciting businesses.

John has 20+ years investment experience, including 14 years in the UK. He spent 3 years as a front office equity analyst for London based hedge fund GLG Partners (previously one of the largest hedge funds globally before being acquired by Man Group). He then went on to work for 8 years at Tesco Pension Investment, a £14B UK pension scheme, as Head of Alternatives - creating, allocating and managing £1.5B in alternative investments globally. John has also been an active angel investor for a number of years. Upon returning to New Zealand in 2015, he co-founded an e-commerce start-up before joining GD1 in 2017. He holds a BSc (Mathematics), 3x Diplomas in Finance, Financial Planning and Statistics, and is a CFA Charterholder. John most recently led investments for GD1 Core Fund 1 into: Auror, Formus Labs, Runn.io, VXT, Simfuni, NextWork, Buddy, Flowingly, Orbica, and Vessev.

Vignesh Kumar is Co-Managing Partner at GD1. He previously co-founded digital oncology platform Journey Health, led engineering execution at Apple across the US and Asia, and designed neonatal resuscitation technology at Fisher & Paykel Healthcare. He is a Kauffman Fellow and Fulbright Scholar with an MBA from Wharton and biomedical engineering qualifications from the University of Auckland.

Matt Wallace co-founded Kamiwaza and is its Chief Technology Officer. SEC filings name him Matthew Wallace, an executive officer and director of the same Kamiwaza Corp. His work centers on enterprise AI, distributed data and inference infrastructure.

Samuel Young is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Humana. This is an advisory or cohort network affiliation, rather than a firm employee position.

Luke Norris co-founded Kamiwaza and is its Chief Executive Officer. SEC filings identify him as Luke Matthew Norris, an executive officer and director of Kamiwaza Corp. The company develops distributed enterprise AI orchestration for regulated and government customers.

Kelly Wang is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Cornell University, Cornell Tech. This is an advisory or cohort network affiliation, rather than a firm employee position.

Gina-Marie Verrone is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Atlantic Health System. This is an advisory or cohort network affiliation, rather than a firm employee position.

Lucie Tyrrell is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Humana. This is an advisory or cohort network affiliation, rather than a firm employee position.

Medical simulation entrepreneur who founded Mentice and worked on its US operations and global commercial partnerships.

Professor of electrical engineering and computer science at Stanford University.

Software engineer and researcher working on VR, machine learning and skills assessment.

Business development professional with experience in exports and administration and degrees from King’s College London and Aristotle University.

Computer scientist with an MSc focused on XR and experience leading medical simulation products.

Lawyer specialising in corporate and commercial law and technology transfer; College of Europe graduate.

University of Crete and ICS-FORTH professor working on computer vision, robotics and augmented reality.

Orthopaedic surgeon and professor affiliated with Aristotle University and Imperial College London.

Computer scientist working on computer graphics and XR algorithms; professor at the University of Crete, formerly at the University of Geneva.

Adviser on regulatory strategy; LL.M. and MBA.

Clinical oncologist and business adviser.

Koios identifies Kourtis as a Gates Ventures ADDF leader, founder and investor. Lampros Kourtis leads the Gates Ventures Diagnostics Accelerator SpeechDx program, according to the March 2026 ADDF Alzheimer’s Insights Summit. His work concerns longitudinal speech research as a potential source of biomarkers across languages. His published biography describes co-founding Chronicles Health, earlier biomaterials ventures, an engineering leadership role at Eli Lilly and a Stanford mechanical-engineering doctorate. These are research activities, not a claim of diagnostic approval.

Koios identifies him as a professor at Karolinska.

Neurology professor at CHU Liège.

Charlotte Thomas is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Signify Health. This is an advisory or cohort network affiliation, rather than a firm employee position.

Chelsea Sumner is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as NVIDIA. This is an advisory or cohort network affiliation, rather than a firm employee position. A longer individual biography is not published on the manager page.